We are live on ! Find out more
PBM icon

Psyence Biomedical
PBM

6 hedge funds and large institutions have $764K invested in Psyence Biomedical in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more capital invested

Capital invested by funds: $625K → $764K (+$138K)

0% more funds holding

Funds holding: 6 → 6 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

44.42% less ownership

Funds ownership: 53.81% → 9.39% (-44%)

Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$45.4K
2
Osaic Holdings
Osaic Holdings
Arizona
+$19.8K
3
AI
AdvisorShares Investments
Maryland
+$4.07K

Top Sellers

Rank Fund Capital Flow
1
PA
Parallel Advisors
California
-$544K
2
SM
Sabby Management
Florida
-$108K
3
UBS Group
UBS Group
Switzerland
-$10.4K

PBM Hedge Fund Activity: Q3 2025 in Review

6 of the 7,645 institutional investors tracked by Wall St. Rank reported a position in Psyence Biomedical (PBM) for Q3 2025, worth a combined $764K — up 22% from $625K a quarter earlier.

Fund positioning in PBM was balanced in Q3 2025: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $45.4K. The largest seller was Parallel Advisors, cutting an estimated $544K.

  • 6 institutional investors held Psyence Biomedical (PBM) as of Q3 2025, unchanged from Q2 2025.
  • Funds reported $764K of Psyence Biomedical stock for Q3 2025, up 22% quarter-over-quarter.
  • 2 funds opened new Psyence Biomedical positions in Q3 2025 and 2 closed out, a net change of 0 holders.
  • The largest Psyence Biomedical buyer in Q3 2025 was Virtu Financial, an estimated $45.4K added.
  • The largest Psyence Biomedical seller in Q3 2025 was Parallel Advisors, an estimated $544K sold.

Based on aggregated 13F filings for Q3 2025.